Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects

Steven P. Millard, Franziska Lutz, Ge Li, Douglas R. Galasko, Martin Farlow, Joseph F. Quinn, Jeffrey A. Kaye, James B. Leverenz, Debby Tsuang, Chang En Yu, Elaine R. Peskind, Lynn M. Bekris

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Low cerebrospinal fluid (CSF) Aβ42 levels correlate with increased brain Aβ deposition in Alzheimer's disease (AD), which suggests a disruption in the degradation and clearance of Aβ from the brain. In addition, APOE ε4 carriers have lower CSF Aβ42 levels than non-carriers. The hypothesis of this investigation was that CSF Aβ42 levels would correlate with regulatory region variation in genes that are biologically associated with degradation or clearance of Aβ from the brain. CSF Aβ42 levels were tested for associations with Aβ degradation and clearance genes and APOE ε4. Twenty-four SNPs located within the 5' and 3' regions of 12 genes were analyzed. The study sample consisted of 99 AD patients and 168 cognitively normal control subjects. CSF Aβ42 levels were associated with APOE ε4 status in controls but not in AD patients; A2M regulatory region SNPs were also associated with CSF Aβ42 levels in controls butnot in AD patients, even after adjusting for APOE ε4. These results suggest that genetic variation within the A2M gene influences CSF Aβ42 levels.

Original languageEnglish
Pages (from-to)357-364
Number of pages8
JournalNeurobiology of Aging
Volume35
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Cerebrospinal Fluid
Alzheimer Disease
Genes
Nucleic Acid Regulatory Sequences
Single Nucleotide Polymorphism
Brain

Keywords

  • A2M
  • Alpha-2-Macroglobulin
  • Alzheimer's disease
  • APOE
  • Cerebrospinal fluid

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects. / Millard, Steven P.; Lutz, Franziska; Li, Ge; Galasko, Douglas R.; Farlow, Martin; Quinn, Joseph F.; Kaye, Jeffrey A.; Leverenz, James B.; Tsuang, Debby; Yu, Chang En; Peskind, Elaine R.; Bekris, Lynn M.

In: Neurobiology of Aging, Vol. 35, No. 2, 02.2014, p. 357-364.

Research output: Contribution to journalArticle

Millard, SP, Lutz, F, Li, G, Galasko, DR, Farlow, M, Quinn, JF, Kaye, JA, Leverenz, JB, Tsuang, D, Yu, CE, Peskind, ER & Bekris, LM 2014, 'Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects', Neurobiology of Aging, vol. 35, no. 2, pp. 357-364. https://doi.org/10.1016/j.neurobiolaging.2013.07.027
Millard, Steven P. ; Lutz, Franziska ; Li, Ge ; Galasko, Douglas R. ; Farlow, Martin ; Quinn, Joseph F. ; Kaye, Jeffrey A. ; Leverenz, James B. ; Tsuang, Debby ; Yu, Chang En ; Peskind, Elaine R. ; Bekris, Lynn M. / Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects. In: Neurobiology of Aging. 2014 ; Vol. 35, No. 2. pp. 357-364.
@article{bf3c1d7906764590aea1ba7bb700ea92,
title = "Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects",
abstract = "Low cerebrospinal fluid (CSF) Aβ42 levels correlate with increased brain Aβ deposition in Alzheimer's disease (AD), which suggests a disruption in the degradation and clearance of Aβ from the brain. In addition, APOE ε4 carriers have lower CSF Aβ42 levels than non-carriers. The hypothesis of this investigation was that CSF Aβ42 levels would correlate with regulatory region variation in genes that are biologically associated with degradation or clearance of Aβ from the brain. CSF Aβ42 levels were tested for associations with Aβ degradation and clearance genes and APOE ε4. Twenty-four SNPs located within the 5' and 3' regions of 12 genes were analyzed. The study sample consisted of 99 AD patients and 168 cognitively normal control subjects. CSF Aβ42 levels were associated with APOE ε4 status in controls but not in AD patients; A2M regulatory region SNPs were also associated with CSF Aβ42 levels in controls butnot in AD patients, even after adjusting for APOE ε4. These results suggest that genetic variation within the A2M gene influences CSF Aβ42 levels.",
keywords = "Aβ, A2M, Alpha-2-Macroglobulin, Alzheimer's disease, APOE, Cerebrospinal fluid",
author = "Millard, {Steven P.} and Franziska Lutz and Ge Li and Galasko, {Douglas R.} and Martin Farlow and Quinn, {Joseph F.} and Kaye, {Jeffrey A.} and Leverenz, {James B.} and Debby Tsuang and Yu, {Chang En} and Peskind, {Elaine R.} and Bekris, {Lynn M.}",
year = "2014",
month = "2",
doi = "10.1016/j.neurobiolaging.2013.07.027",
language = "English",
volume = "35",
pages = "357--364",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects

AU - Millard, Steven P.

AU - Lutz, Franziska

AU - Li, Ge

AU - Galasko, Douglas R.

AU - Farlow, Martin

AU - Quinn, Joseph F.

AU - Kaye, Jeffrey A.

AU - Leverenz, James B.

AU - Tsuang, Debby

AU - Yu, Chang En

AU - Peskind, Elaine R.

AU - Bekris, Lynn M.

PY - 2014/2

Y1 - 2014/2

N2 - Low cerebrospinal fluid (CSF) Aβ42 levels correlate with increased brain Aβ deposition in Alzheimer's disease (AD), which suggests a disruption in the degradation and clearance of Aβ from the brain. In addition, APOE ε4 carriers have lower CSF Aβ42 levels than non-carriers. The hypothesis of this investigation was that CSF Aβ42 levels would correlate with regulatory region variation in genes that are biologically associated with degradation or clearance of Aβ from the brain. CSF Aβ42 levels were tested for associations with Aβ degradation and clearance genes and APOE ε4. Twenty-four SNPs located within the 5' and 3' regions of 12 genes were analyzed. The study sample consisted of 99 AD patients and 168 cognitively normal control subjects. CSF Aβ42 levels were associated with APOE ε4 status in controls but not in AD patients; A2M regulatory region SNPs were also associated with CSF Aβ42 levels in controls butnot in AD patients, even after adjusting for APOE ε4. These results suggest that genetic variation within the A2M gene influences CSF Aβ42 levels.

AB - Low cerebrospinal fluid (CSF) Aβ42 levels correlate with increased brain Aβ deposition in Alzheimer's disease (AD), which suggests a disruption in the degradation and clearance of Aβ from the brain. In addition, APOE ε4 carriers have lower CSF Aβ42 levels than non-carriers. The hypothesis of this investigation was that CSF Aβ42 levels would correlate with regulatory region variation in genes that are biologically associated with degradation or clearance of Aβ from the brain. CSF Aβ42 levels were tested for associations with Aβ degradation and clearance genes and APOE ε4. Twenty-four SNPs located within the 5' and 3' regions of 12 genes were analyzed. The study sample consisted of 99 AD patients and 168 cognitively normal control subjects. CSF Aβ42 levels were associated with APOE ε4 status in controls but not in AD patients; A2M regulatory region SNPs were also associated with CSF Aβ42 levels in controls butnot in AD patients, even after adjusting for APOE ε4. These results suggest that genetic variation within the A2M gene influences CSF Aβ42 levels.

KW - Aβ

KW - A2M

KW - Alpha-2-Macroglobulin

KW - Alzheimer's disease

KW - APOE

KW - Cerebrospinal fluid

UR - http://www.scopus.com/inward/record.url?scp=84887215635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887215635&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2013.07.027

DO - 10.1016/j.neurobiolaging.2013.07.027

M3 - Article

C2 - 24011543

AN - SCOPUS:84887215635

VL - 35

SP - 357

EP - 364

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 2

ER -